| 英文别名 |
WYE-354;WYE 354;4-[6-[4-[(methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-Piperidinecarboxylic acid methyl ester;Methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;pyrazolo pyrimidine,19;WYE-354 (Degrasyn);Methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pip;methyl 4-[6-[4-(methoxycarbonylamino)phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;AC-28454;SB19260;DB-059456;methyl 4-(6-(4-((methoxycarbonyl)amino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;pyrazolo pyrimidine, 19;SMR004702806;CCG-264882;AKOS027314120;J-514253;mTOR Kinase Inhibitor II, WYE-354 - CAS 1062169-56-5;MLS006011008;NCGC00242484-01;AS-55957;BCP0726000260;SCHEMBL300431;S1266;4-[6-[4-(methoxycarbonylamino)phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;CHEMBL561708;BRD-K77008974-001-01-6;J-001552;EX-A5295;4-[6-[4-[(Methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylic acid methyl ester;methyl 4-(6-{4-[(methoxycarbonyl)amino]phenyl}-4-(morpholin-4-yl)pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;GLXC-02756;NCGC00242484-02;WYE-354?;HY-12034;HMS3654N09;BRD-K77008974-001-03-2;DTXSID00657912;D83184;SDCCGSBI-0654362.P001;CHEBI:94742;SW219671-1;GTPL9361;NCGC00242484-09;4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester;BDBM35587;Q27166532;Methyl 4-[6-{4-[(methoxycarbonyl)amino]phenyl}-4-(morpholin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;CS-0183;BCP02898;1062169-56-5 |